Age(year) |
X2
= 1.13, p-value = 0.77 |
Sex of respondents |
X2 = 0.001 p-value = 0.995 |
Mother HIV status |
X2 = 2.30,p-value = 0.317 |
Relationship to the child |
X2 = 6.93, p-value = 0.74 |
Residence |
X2 = 3.54,p-vaue = 0.60 |
Place of health service utilization |
X2 = 1.17,p-value = 0.27 |
Family size |
X2 = 0.28,p-value = 0.86 |
Age of caregiver |
X2 = 2.44,p-value = 0.48 |
WHO clinical stage |
X2 = 1.03,p-value = 0.30 |
HIV status of the caregiver |
X2 = 0.61,p-value = 0.97 |
Initial regimen |
X2 = 10.42,p-value = 0.06 |
Treatment failure |
X2 = 0.037,p-value = 0.84 |
Immunologic failure |
X2 = 0.49,p-value = 0.48 |
Virologic failure |
X2 = 0.003,p-value = 0.95 |
Clinical failure |
X2 = 2.52,p-value = 0.112 |
Weight for age |
X2 = 0.086,p-value = 0.77 |
Height for age |
X2 = 0.015,p-value = 0.090 |
Adherence to ART |
X2 = 84.80,p-value = 0.0001 |
Type of TB |
X2 = 73.53, p-value = 0.0001 |
Cotrimoxazole |
X2 = 52.28, p-value = 0.0001 |
Isoniazid preventive therapy |
X2 = 56.32, p-value = 0.0001 |
Functional status |
X2 = 2.17,p-value = 0.337 |
Hgb level at TB diagnose |
X2 = 86.23, p-value = 0.0001 |